Cargando…

Prognostic impact of tumor mutation burden and the mutation in KIAA1211 in small cell lung cancer

BACKGROUND: Small cell lung cancer (SCLC) is a highly aggressive lung cancer subtype with poor survival and limited treatment options. Sequencing results have revealed gene mutations associated with SCLC, however, the correlation between the genomic alterations and clinical prognosis of SCLC is yet...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Mengting, Fan, Jun, Li, Zhenyu, Li, Pindong, Sun, Yajie, Yang, Yuhui, Zhou, Xiaoshu, Wang, Jing, Wang, Ye, Qi, Huiwei, Cai, Weijing, Dai, Xiaofang, Hirsch, Fred R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836503/ https://www.ncbi.nlm.nih.gov/pubmed/31699089 http://dx.doi.org/10.1186/s12931-019-1205-9

Ejemplares similares

Analysis of Uncharacterized mKiaa1211 Expression during Mouse Development and Cardiovascular Morphogenesis
por: L. Snider, Paige, et al.
Publicado: (2019)

KIAA1211 plays an oncogenic role in human non-small cell lung cancer
por: Liu, Zhengcheng, et al.
Publicado: (2019)

Systematic mutation analysis of KIAA0767 and KIAA1646 in chromosome 22q-linked periodic catatonia
por: Stöber, Gerald, et al.
Publicado: (2005)

Novel KIAA0753 mutations extend the phenotype of skeletal ciliopathies
por: Hammarsjö, A., et al.
Publicado: (2017)

KIAA1549: BRAF Gene Fusion and FGFR1 Hotspot Mutations Are Prognostic Factors in Pilocytic Astrocytomas
por: Becker, Aline Paixão, et al.
Publicado: (2015)

Stratified analyses of genome wide association study data reveal haplotypes for a candidate gene on chromosome 2 (KIAA1211L) is associated with opioid use in patients of Arabian descent
por: Alblooshi, Hiba, et al.
Publicado: (2020)

Association of a Novel Nonsense Mutation in KIAA1279 with Goldberg-Shprintzen Syndrome
por: SALEHPOUR, Shadab, et al.
Publicado: (2017)

Correction to Lancet Oncol 2019; 20: 1211–25
Publicado: (2019)

Correction to Lancet Oncol 2019; 20: 1211–25
Publicado: (2021)

Poor Prognostic Biomarker KIAA1522 Is Associated with Immune Infiltrates in Hepatocellular Carcinoma
por: Shi, Yongjie, et al.
Publicado: (2023)

KIAA0556 is a novel ciliary basal body component mutated in Joubert syndrome
por: Sanders, Anna A. W. M., et al.
Publicado: (2015)

De novo mutations of KIAA2022 in females cause intellectual disability and intractable epilepsy
por: de Lange, Iris M, et al.
Publicado: (2016)

An miRNA signature associated with tumor mutation burden in endometrial cancer
por: Zhou, Hongyu, et al.
Publicado: (2020)

X-ray spectrum and variability of the quasar PG1211+143
por: Yaqoob, T, et al.
Publicado: (1994)

Functional genome-wide siRNA screen identifies KIAA0586 as mutated in Joubert syndrome
por: Roosing, Susanne, et al.
Publicado: (2015)

KIAA1109 gene mutation in surviving patients with Alkuraya-Kučinskas syndrome: a review of literature
por: Kumar, Kishore, et al.
Publicado: (2020)

A novel KIAA0196 mutation in a Chinese patient with spastic paraplegia 8: A case report
por: Ma, Limin, et al.
Publicado: (2018)

Identification of SCN7A as the key gene associated with tumor mutation burden in gastric cancer
por: Li, Wenjie, et al.
Publicado: (2022)

Association between Occupation and Cervical Disc Degeneration in 1211 Asymptomatic Subjects
por: Machino, Masaaki, et al.
Publicado: (2022)

A Functional Mutation in KIAA1462 Promoter Decreases Glucocorticoid Receptor Affinity and Affects Egg-Laying Performance in Yangzhou Geese
por: Xia, Mengyuan, et al.
Publicado: (2018)

Correlations Between Tumor Mutation Burden and Immunocyte Infiltration and Their Prognostic Value in Colon Cancer
por: Zhou, Zhangjian, et al.
Publicado: (2021)

Overexpression of KIAA1199 is an independent prognostic marker in laryngeal squamous cell carcinoma
por: Huang, Meixiang, et al.
Publicado: (2020)

Predicting Tumor Mutation Burden and EGFR Mutation Using Clinical and Radiomic Features in Patients with Malignant Pulmonary Nodules
por: Yin, Wenda, et al.
Publicado: (2022)

Serum KIAA1199 is an advanced-stage prognostic biomarker and metastatic oncogene in cholangiocarcinoma
por: Zhai, Xiangyu, et al.
Publicado: (2020)

1211. Assessing the Applicability of Enhanced Barrier Precautions among Adult Hospitalized Patients
por: Makhija, Jinal, et al.
Publicado: (2022)

The arrhythmogenic cardiomyopathy phenotype associated with PKP2 c.1211dup variant
por: Bos, Thomas A., et al.
Publicado: (2023)

Mutations in KIAA1109, CACNA1C, BSN, AKAP13, CELSR2, and HELZ2 Are Associated With the Prognosis in Endometrial Cancer
por: Qiao, Zhiwei, et al.
Publicado: (2019)

Oestrogen receptor negative-progesterone receptor positive phenotype in 1,211 breast tumours.
por: Pichon, M. F., et al.
Publicado: (1992)

Texting while driving: A study of 1211 U.S. adults with the Distracted Driving Survey
por: Gliklich, Emily, et al.
Publicado: (2016)

P1211: CLINICAL HETEROGENEITY OF HIGH-GRADE B-CELL LYMPHOMA. EDGE OF TRANSFORMATION.
por: Misyurina, A., et al.
Publicado: (2022)

Prognostic role of TSPAN1, KIAA1324 and ESRP1 in prostate cancer
por: Stinnesbeck, Melissa, et al.
Publicado: (2021)

TALPID3 controls centrosome and cell polarity and the human ortholog KIAA0586 is mutated in Joubert syndrome (JBTS23)
por: Stephen, Louise A, et al.
Publicado: (2015)

ALS5/SPG11/ KIAA1840 mutations cause autosomal recessive axonal Charcot–Marie–Tooth disease
por: Montecchiani, Celeste, et al.
Publicado: (2016)

Mucin 4 mutation is associated with tumor mutation burden and promotes antitumor immunity in colon cancer patients
por: Peng, Linglong, et al.
Publicado: (2021)

A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation
por: Fu, Jing, et al.
Publicado: (2021)

CD1B is a Potential Prognostic Biomarker Associated with Tumor Mutation Burden and Promotes Antitumor Immunity in Lung Adenocarcinoma
por: Li, Zhou, et al.
Publicado: (2022)

Mutation status and burden can improve prognostic prediction of patients with lower‐risk myelodysplastic syndromes
por: Jiang, Lingxu, et al.
Publicado: (2019)

KIAA1522 is a novel prognostic biomarker in patients with non-small cell lung cancer
por: Liu, Yi-Zhen, et al.
Publicado: (2016)

Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma
por: Xu, Qianhui, et al.
Publicado: (2021)

Identification of Prognostic Biomarkers of Cutaneous Melanoma Based on Analysis of Tumor Mutation Burden
por: Lin, Jiaqiong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5e7pahrtbp6p09h9urtmr66d3q